ADVERTISEMENT
ADVERTISEMENT

Alzheimer's: Type 3 Diabetes?

Neurodegeneration research turns to insulin for answers

kerry grens
Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at...

View full profile.


Learn about our editorial policies.

In 2005, while testing the effects of impaired insulin signaling on the brain, Suzanne de la Monte at Brown University and her colleagues observed several unexpected phenomena in her experimental mice. Hallmarks of neurodegenerative disease had surfaced: oxidative stress, amyloid fibrils, and cell loss. "It was the craziest thing," de la Monte says. Glucose metabolism and Alzheimer's had been linked previously, says de la Monte, and perhaps her findings explained why.

Looking in the brains of patients diagnosed with Alzheimer's disease, de la Monte found reductions in insulin, insulin-like growth factor, and downstream elements such as tau, insulin receptor substrate, and kinases.1 Type 1 diabetes is a deficiency in...

References

1. E. Steen et al., "Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - Is this type 3 diabetes?" J Alzheimer Dis, 7:63-80, 2005. 2. A. Taguchi et al., "Brain IRS2 signaling coordinates lifespan and nutrient homeostasis," Science, 317:369-72, 2007

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT